Updated: Jul 20, 2009
Enchondromas are benign cartilaginous neoplasms that are usually solitary lesions in intramedullary bone. The primary significant factors of enchondromas are related to their complications, most notably pathologic fracture, and a small incidence of malignant transformation, which may be associated with pathologic fracture.1
When multiple enchondromas coexist, the diagnosis of enchondromatosis should be considered.
Multiple enchondromas may occur in 3 distinct disorders:
Recent studies
In a study from 1998 to 2005, 35 enchondromas of the hand were diagnosed in 16 women and 19 men averaging 36 years of age (age range, 16-66 years), with 17 cases in the proximal phalanx, 8 cases in the metacarpal bone, 5 cases in the middle phalanx, and 5 cases in the carpal bones. Surgery was performed in 29 patients. Of 27 patients who underwent follow-up examination, 25 showed an excellent result. In 2 patients, the result was assessed as good because of restricted mobility resulting from scar formation. The authors concluded from study findings that for accurate diagnosis, conventional radiographic examination and, if necessary, contrast-enhanced MRI should be performed. In addition, histologic investigation was determined to be compulsory because of the risk of malignancy.2
Oncologic and functional results of curettage and cryosurgery were analyzed in 123 patients with 130 tumors consisting of 75 enchondromas and 55 grade 1 chondrosarcomas. During follow-up, there was one local recurrence of an active enchondroma and one local recurrence of an aggressive enchondroma, both of which were treated with curettage and cryosurgery again. Both patients were disease-free at a minimum of 3 years follow-up, and there were no local recurrences after treatment of grade 1 chondrosarcoma were. Curettage and cryosurgery for enchondroma and grade 1 chondrosarcoma showed excellent oncologic and functional results, according to the authors.3
Enchondromas are ectopic hyaline cartilage rests in intramedullary bone. The lesions replace normal bone with mineralized or unmineralized hyaline cartilage, thereby generating a lytic pattern on radiographs or, more commonly, a lytic area containing rings and arcs of chondroid calcifications. The lesions likely arise from cartilaginous rests that are displaced from the growth plate.
Endosteal growth may occur and does not imply malignant transformation in the hands and feet, wherein the lesions appear to be more cellular. Although the extent of cellularity is not correlated with malignant transformation, mitotic figures are seldom seen in the lesions, and their presence may be correlated with malignancy. Pathologic fracture predisposed by thinning of the cortex is not typically associated with malignancy in the hands and feet; however, in other areas such as the long bones and flat bones, pathologic fracture is suggestive of malignant transformation.
Complete transgression through the cortex with a soft-tissue component is highly suggestive of malignancy. Although malignant transformation to several types of tumors is reported, chondrosarcoma is the most common by far.
Enchondromas account for 12-14% of benign bone neoplasms and 3-10% of osseous neoplasms in general.4
Most often, enchondromas are of no consequence and patients are asymptomatic. Enchondromas are not life threatening; however, painful malignant transformation should be the primary concern and cannot be excluded, even in the presence of a benign appearance on radiographs and images from other modalities. Malignant transformation is virtually nonexistent in the hands and feet but may be seen in the long bones and flat bones.
No racial predilection is known.
Enchondromas occur equally in males and females.
Solitary enchondromas most often are discovered in those aged 20-40 years. Ollier disease is usually detected in those aged 0-10 years.
Studies have shown that the association between enchondromatosis and intracranial malignancy is approximately the same in children and adults, although Ollier disease does seem to occur most often in children.8,9
Solitary enchondromas are intramedullary lesions, although they may expand enough to cause endosteal scalloping of the cortex. They have a predilection for the small bones of the hands and feet, where most occur. Of these, half are in the proximal phalanx, followed in frequency by the metacarpal and middle phalanx and, lastly, by the distal phalanges and carpus. Other locations are the shoulder, pelvis, and long bones. Enchondromas tend to occupy the diaphyseal region in the short tubular bones and the metaphyseal region in the longer bones. Ollier disease occurs with highest frequency in the long bones.10
Approximately 50% of solitary enchondromas are found in the hands, typically in the middle and distal portions of the metacarpals and the proximal portions of the phalanges.4 The next most common sites are the proximal and distal parts of the femur and the proximal part of the humerus. Enchondromas at the mid shaft of the tibia are rare.
When patients have pain and/or rapid growth of the lesion, malignant transformation should be suspected, even in the absence of suggestive radiographic findings. Enchondromas are metabolically active and may continue to grow and evolve throughout the patient's lifetime; thus, progressive calcification over a period of years is not unusual. Loss of calcification in a focal region suggests malignant degeneration with destruction of the underlying enchondroma by sarcomatous tissue.11
Primary clinical complications include pathologic fracture and malignant transformation, which may be concomitant. In particular, pathologic fracture does not imply malignant transformation in the hands and feet, in which endosteal scalloping and cortical thinning may be extensive without malignant transformation.
When the lesion has calcifications, the primary differential diagnoses are bone infarct and chondrosarcoma. When the lesion is purely lytic, as shown on radiographs, the differential diagnosis consists of benign lytic lesions such as nonossifying fibroma, simple bone cyst, fibrous dysplasia, eosinophilic granuloma, and clear cell chondrosarcoma (which tends to involve the end of the bone—in particular, the proximal humerus).
Initially, radiography is the imaging modality of choice. If further characterization is necessary, magnetic resonance imaging (MRI) or computed tomography (CT) scanning is performed. If uncertainty remains, bone scanning may be helpful, but some lesions require biopsy.
Radiographic findings may not demonstrate or adequately characterize subtle calcifications to the extent that CT scans do. When calcifications are not present on either examination, MRI may be performed, which should reveal the classic appearance of noncalcified hyaline cartilage. Dystrophic calcifications in bone infarcts may be difficult to differentiate from chondroid matrix with ionizing radiation, and MRI may be helpful in these cases.
Occasionally, dystrophic calcifications in bone infarcts may be difficult to differentiate from enchondromas on plain radiographs. When a clearly serpiginous rind of sclerosis encapsulates the lesion, the diagnosis of bone infarct is straightforward; however, when this finding is not present, MRI may be useful in differentiating the 2 entities.
In lesions in which calcifications are not seen radiographically, the diagnosis may be made with the help of MRIs. CT scans may demonstrate the presence of calcification not depicted on radiographs.
Chondrosarcoma — in particular, low-grade chondrosarcoma — may be indistinguishable from enchondroma. Certain imaging features may be helpful in distinguishing enchondroma from chondrosarcoma (see Radiograph section below). However, even a lesion with no imaging features suggestive of malignancy and an imaging appearance compatible with an enchondroma should be resected when it is associated with pain. Low-grade chondrosarcoma may be indistinguishable from enchondroma on all images, and the diagnosis may be difficult, even with histologic evaluation.
Chondrosarcoma
Bone infarct
Benign lytic lesions - Nonossifying fibroma, simple bone cyst, fibrous dysplasia, eosinophilic granuloma, clear cell chondrosarcoma
A classic pattern of calcifications, described as rings and arcs, is pathognomonic when it is seen in the hands. In the long bones, calcifications may be difficult to distinguish from the dystrophic calcifications seen in bone infarction. In addition, radiographs may not depict the rings and arcs of calcifications, particularly in the hands and feet.
Low-grade chondrosarcoma may be indistinguishable from enchondroma; however, in most cases, chondrosarcoma has certain imaging features that are indicative of its aggressive behavior. Cortical breakthrough, soft-tissue mass, and deep endosteal scalloping of the cortex are 3 features that are described more frequently in chondrosarcoma. However, deep endosteal scalloping with consequent pathologic fracture in the small bones of the hands and feet does not imply malignancy, because enchondromas are more cellular and expansile in these locations.
In Ollier disease, enchondromas often appear to be larger than they do in other conditions. Because enchondromas occur in young patients and can be large, growth of the affected limbs may be adversely affected, and pathologic fractures may occur. Enchondromatosis can occasionally have the appearance of linear lucencies, in which the chondrocytes appear to line up in a vertical orientation along the length of the bone.
In Maffucci syndrome, associated soft-tissue hemangiomas are seen. Soft-tissue hemangiomas typically have numerous rounded calcifications with central lucencies, which are consistent with phleboliths on plain radiograph. T2-weighted MRIs of these lesions show high-signal-intensity tubular structures, which are consistent with slow flow in vascular channels.
Metachondromatosis has associated osteochondromas, which differ from conventional osteochondromas in that they point toward rather than away from the joint.
On radiographs, the degree of confidence in the diagnosis of an enchondroma depends on the clinical situation and the appearance of the lesion. In the presence of pain, almost regardless of appearance, further investigation is warranted. Lesions that are predominantly lucent or are nonuniformly mineralized often require further investigation as well.
In most cases, enchondroma and a low-grade chondrosarcoma cannot be reliably distinguished on the basis of radiographic findings alone. A calcified enchondroma can also mimic the appearance of a calcified marrow infarct.
The features of enchondroma on CT scan are the same as those depicted on radiographs.
Enchondromas are endosteal lesions with a lobular morphology and variable mineralization. Often, the mineralization is in the form of rings and arcs, which correspond to calcification around lobules of cartilage. A pathologic fracture may be present. Sometimes, endosteal scalloping is present, but this feature may be suggestive of degeneration of the enchondroma to a chondrosarcoma. Enchondromas should not penetrate the cortex or extend into the soft tissues.
If a densely mineralized or uniformly mineralized lesion has a region that is lucent, degeneration of the enchondroma to a chondrosarcoma is suggested, and biopsy is likely necessary.
As with radiographs, the degree of confidence in the diagnosis of an enchondroma with CT scanning depends on the clinical situation and the appearance of the lesion. The absence of pain, uniform or dense mineralization, and endosteal scalloping or cortical penetration are all indications of an enchondroma. However, if the patient lacks any of these features, further investigation may be necessary.
Distinguishing an enchondroma from a low-grade chondrosarcoma is often problematic; sometimes, the diagnosis cannot be resolved without a biopsy. Because cartilage lesions are often not uniform at histologic examination, the entire lesion may need to be removed at biopsy.
MRI findings may be useful in distinguishing enchondromas in the long bones from bone infarcts. Typically, bone infarcts are encapsulated by a serpiginous rind of decreased signal intensity on T1- and T2-weighted images. Frequently, this rind is subtended by a high-signal-intensity line. This finding has been called the double-line sign, and it consists of a high-signal-intensity rind circumscribed by and immediately adjacent to a low-signal-intensity rind on T2-weighted images.
Conversely, enchondromas tend to have lobulated borders with a cluster of numerous tiny locules of high-signal-intensity foci on T2-weighted images that appear to coalesce with one another and reflect the high fluid content of hyaline cartilage. On T1-weighted images, enchondromas demonstrate low-to-intermediate signal intensity.
When a calcific chondroid matrix is observed on radiographs, decreased signal intensity is expected to occur in those areas on images obtained with all MRI pulse sequences. These areas may become particularly pronounced on gradient-echo images.
When combined with a typical appearance on radiographs and an absence of pain, the diagnosis of enchondroma with MRI findings can be made with a high degree of confidence. Enchondromas may also be incidental findings at routine examination, such as MRI of the knee. If the lesions have a typical appearance, a confident diagnosis may be made; however, the acquisition of correlative radiographic findings is often prudent.
Occasionally, enchondromas can be difficult to distinguish from other intraosseous benign and malignant lesions on the basis of MRI findings alone. Correlation with other results, particularly radiographic results, may help. The presence of bone pain always warrants further investigation.
Ultrasonography is not used in the diagnosis of enchondroma.
With technetium-99m (99m Tc) radionuclide bone scanning, findings are typically negative in uncomplicated enchondromas, but the presence of pathologic fracture results in intense activity at the fracture site. In patients with multiple enchondromas or patients in whom an enchondroma is actively calcifying, radionuclide bone scans may show increased activity, but the activity is typically less intense than that of intramedullary chondrosarcomas.
Positron emission tomography (PET) using 18-fluorodeoxyglucose (18-FDG) has been applied increasingly to the evaluation of tumors. Using PET to evaluate enchondromas—particularly to distinguish benign enchondromas from low-grade chondrosarcomas—has been reported in small series. In a study by Feldman et al, 11 enchondromas were studied by PET with 18-FDG; the maximum standard uptake values (SUVs) ranged from 0.8 to 1.8.12 The authors established a maximum SUV of 2.0 as the cutoff between benign and malignant; 10 of the 11 chondrosarcomas in their study had maximum SUVs ranging from 2.4 to 12.4. Feldman et al recommended 18-FDG PET as an adjunct for the evaluation of aggressive cartilage lesions. A hypometabolic lesion would not require biopsy.
Radionuclide bone scanning is one method used to assess lesions depicted on radiographs or MRIs that are presumed to be enchondromas. If the bone scan results are negative, the possibility of a malignancy (eg, chondrosarcoma) is extremely remote. If the scan results are positive, biopsy is typically necessary. Radionuclide bone scan findings are not reliable in differentiating enchondroma from calcified marrow infarct.
Radionuclide bone scan findings are nonspecific; therefore, one cannot reliably diagnose a focal bone lesion on the basis of these findings alone. However, the physiologic information provided by a bone scan, when combined with information from other imaging modalities, can be helpful.
The 18-FDG PET imaging study of cartilage lesions by Feldman et al included one lesion that was considered a borderline chondrosarcoma.12 This lesion had a maximum SUV of 1.4, which was below the value of 2.0 that they used as the cutoff between benign and malignant.
Angiography is not used in the diagnosis or evaluation of solitary enchondroma. In Maffucci syndrome, angiography may play a secondary role in identifying the extent and origin of the vascular malformation.
CT-guided percutaneous needle biopsy occasionally is indicated in the management of enchondroma. However, because benign and low-grade malignant cartilage lesions may be difficult to distinguish at histologic examination, the risk of sampling error usually precludes a confident diagnosis. Therefore, needle biopsy is not generally useful.
If CT scans show a densely mineralized or uniformly mineralized lesion with a lucent region, degeneration of the enchondroma to a chondrosarcoma is suggested, and biopsy is likely necessary.
Semenova LA, Bulycheva IV. [Chondromas (enchondroma, periosteal chondroma, enchondromatosis)]. Arkh Patol. Sep-Oct 2007;69(5):45-8. [Medline].
Figl M, Leixnering M. Retrospective review of outcome after surgical treatment of enchondromas in the hand. Arch Orthop Trauma Surg. Jun 2009;129(6):729-34. [Medline].
van der Geest IC, de Valk MH, de Rooy JW, Pruszczynski M, Veth RP, Schreuder HW. Oncological and functional results of cryosurgical therapy of enchondromas and chondrosarcomas grade 1. J Surg Oncol. Nov 1 2008;98(6):421-6. [Medline].
Unni KK. Dahlin's Bone Tumors: General Aspects and Data on 11,087 Cases. 5th ed. Philadelphia, Pa: Lippincott-Raven;1996:25-45.
Katz P, Colbert R, Drolet B. Unilateral mosaic cutaneous vascular lesions, enchondroma, multiple soft tissue chondromas and congenital fibrosarcoma--a variant of Maffucci syndrome?. Pediatr Dermatol. Mar-Apr 2008;25(2):205-9. [Medline].
Sun GH, Myer CM 3rd. Otolaryngologic manifestations of Maffucci's syndrome. Int J Pediatr Otorhinolaryngol. Jul 2009;73(7):1015-8. [Medline].
Springfield DS, Gebhardt MC, McGuire MH. Chondrosarcoma: a review. J Bone Joint Surg [Am]. 1996;78:141-9.
D'Angelo L, Massimi L, Narducci A, Di Rocco C. Ollier disease. Childs Nerv Syst. Jun 2009;25(6):647-53. [Medline].
Ranger A, Szymczak A. The association between intracranial tumours and multiple dyschondroplasia (Ollier's disease or Maffucci's syndrome): do children and adults differ?. J Neurooncol. Jun 9 2009;[Medline].
Moser T, Lin XZ, Bazille G, Fleury M, Dietemann JL, Kremer S. Progressive hemianopsia caused by intracranial enchondroma in Ollier disease. Neurology. Dec 9 2008;71(24):2018. [Medline].
Al Kaissi A, Ganger R, Klaushofer K, Rumpler M, Grill F. Achondroplasia manifesting as enchondromatosis and ossification of the spinal ligaments: a case report. J Med Case Reports. Aug 11 2008;2:263. [Medline].
Feldman F, Van Heertum R, Saxena C, et al. 18FDG-PET applications for cartilage neoplasms. Skeletal Radiol. Jul 2005;34(7):367-74.
Bauer HC, Brosjo O, Kreicbergs A, et al. Low risk of recurrence of enchondroma and low-grade chondrosarcoma in extremities. 80 patients followed for 2-25 years. Acta Orthop Scand. Jun 1995;66(3):283-8. [Medline].
Flemming DJ, Murphey MD. Enchondroma and chondrosarcoma. Semin Musculoskelet Radiol. 2000;4(1):59-71. [Medline].
Healey JH, Lane JM. Chondrosarcoma. Clin Orthop Relat Res. Mar 1986;119-29. [Medline].
Hudson TM, Chew FS, Manaster BJ. Radionuclide bone scanning of medullary chondrosarcoma. AJR Am J Roentgenol. Dec 1982;139(6):1071-6. [Medline].
Jaffe HL, Lichtenstein L. Solitary benign enchondroma of bone. Arch Surg. 1943;46:480-93.
Marco RA, Gitelis S, Brebach GT, Healey JH. Cartilage tumors: evaluation and treatment. J Am Acad Orthop Surg. Sep-Oct 2000;8(5):292-304. [Medline].
McDermott AL, Dutt SN, Chavda SV, Morgan DW. Maffucci''s syndrome: clinical and radiological features of a rare condition. J Laryngol Otol. Oct 2001;115(10):845-7. [Medline].
Murphey MD, Flemming DJ, Boyea SR, et al. Enchondroma versus chondrosarcoma in the appendicular skeleton: differentiating features. Radiographics. Sep-Oct 1998;18(5):1213-37; quiz 1244-5. [Medline].
Peiper M, Zornig C. Chondrosarcoma of the thumb arising from a solitary enchondroma. Arch Orthop Trauma Surg. 1997;116(4):246-8. [Medline].
Robbin MR, Murphey MD. Benign chondroid neoplasms of bone. Semin Musculoskelet Radiol. 2000;4(1):45-58. [Medline].
Wang XL, De Beuckeleer LH, De Schepper AM, Van Marck E. Low-grade chondrosarcoma vs enchondroma: challenges in diagnosis and management. Eur Radiol. 2001;11(6):1054-7. [Medline].
Zwenneke Flach H, Ginai AZ, Wolter Oosterhuis J. Best cases from the AFIP. Maffucci syndrome: radiologic and pathologic findings. Armed Forces Institutes of Pathology. Radiographics. Sep-Oct 2001;21(5):1311-6. [Medline]. [Full Text].
enchondroma, enchondromatosis, chondroma, chondrosarcoma, Ollier's disease, Ollier disease, Maffucci syndrome, dystrophic calcifications, benign cartilaginous neoplasms, benign bone neoplasms, osseous neoplasms, pathologic bone fracture, hyaline cartilage rests
Felix S Chew, MD, MBA, EdM, Professor, Department of Radiology, Vice Chairman for Radiology Informatics, Section Head of Musculoskeletal Radiology, University of Washington
Felix S Chew, MD, MBA, EdM is a member of the following medical societies: American Roentgen Ray Society, Association of University Radiologists, and Radiological Society of North America
Disclosure: Nothing to disclose.
T Catherine Maldjian, MD, Associate Professor, Department of Radiology, New York Medical College; Director, Radiology Research Center; Chief, Musculoskeletal Radiology, Westchester Medical Center
T Catherine Maldjian, MD is a member of the following medical societies: American Roentgen Ray Society, Association of University Radiologists, International Skeletal Society, Radiological Society of North America, and Society of Skeletal Radiology
Disclosure: Nothing to disclose.
Michael A Bruno, MD, Associate Professor, Departments of Radiology and Medicine, Pennsylvania State University College of Medicine; Director, Radiology Quality Management Services, Milton S Hershey Medical Center, Pennsylvania State University College of Medicine
Michael A Bruno, MD is a member of the following medical societies: American College of Radiology, American Roentgen Ray Society, Association of University Radiologists, Radiological Society of North America, Society of Nuclear Medicine, and Society of Skeletal Radiology
Disclosure: Nothing to disclose.
Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand
Disclosure: Nothing to disclose.
Murali Sundaram, MBBS, FRCR, FACR, Consulting Staff, Department of Diagnostic Radiology, The Cleveland Clinic Foundation
Disclosure: Nothing to disclose.
Robert M Krasny, MD, Consulting Staff, Department of Radiology, The Angeles Clinic and Research Institute
Robert M Krasny, MD is a member of the following medical societies: American Roentgen Ray Society and Radiological Society of North America
Disclosure: Nothing to disclose.
Felix S Chew, MD, MBA, EdM, Professor, Department of Radiology, Vice Chairman for Radiology Informatics, Section Head of Musculoskeletal Radiology, University of Washington
Felix S Chew, MD, MBA, EdM is a member of the following medical societies: American Roentgen Ray Society, Association of University Radiologists, and Radiological Society of North America
Disclosure: Nothing to disclose.
Related eMedicine topics
Simple Bone Cyst
Aneurysmal Bone Cyst (from Radiology)
Aneurysmal Bone Cyst (from Orthopedic Surgery)
Unicameral Bone Cyst
Non-neoplastic Conditions Simulating Bone Tumors
Clinical guidelines
ACR Appropriateness Criteria Bone Tumors
ACR Appropriateness Criteria® follow-up of malignant or aggressive musculoskeletal tumors. American College of Radiology - Medical Specialty Society. 1998 (revised 2006). 11 pages. [NGC Update Pending] NGC:005117
© 1994-
by Medscape.
All Rights Reserved
(http://www.medscape.com/public/copyright)